Applications will be accepted on a rolling basis through March 30, 2022
NIDA is issuing this Notice of Special Interest (NOSI) to highlight the urgent need for continued research on the impacts of SARS-CoV-2, the coronavirus that causes COVID-19. NIDA is especially interested in research collecting and examining data on the risks and outcomes for COVID-19 infection in individuals suffering from substance use disorders.
Topics: Clinical Presentation of Infection, ARDS, Cellular / Molecular Response, Inflammation, Long-term Impact of Infection, Pneumonia, Sensory, Clinical Trial, Co-Morbidities, Asthma, Cirrhosis, COPD, COVID-19, Diabetes, Immune Disorders, HIV, Neurological Disorders, Substance Abuse, Community Engagement, Computational or Data Science Methods Development, Environmental Health, Epidemiology, Clinical History, Clinical Outcome, Incidence, Risk Factors, Surveillance, Transmission, Aerosol, Health Disparities, Healthcare Implementation, Immunity, Host Factors, Host Response, Mental Health, Physician Well-being, Psychology, Resident Well-being, Mobile Health, App, Telemedicine, Wearables, Oral Science / Dentistry, Prevention, PPE, Research Site, Community-based, Social Determinants of Health, Target Population, Elderly, Homeless Persons, Military Personnel, Prisoners, Service Workers, Teens, Treatments, Antibody-based Treatment, Convalescent Serum, Drug Development, Drug Repurposing, Drug Targets, Anti-viral Targets, Immunological Response Targets, Drugs, Immunological Response Targets, Treatment Efficacy, Treatment Reliability, Treatment Scalability, Vaccine Development, Vaccine Efficacy, Vaccine Reliability, Vaccine Scalability, Vaccines, Vaccine Hesitancy, Virology, Viral Interactome, Viral Proteins, Virus Biology, Virus Evolution, Virus Factors